The pooled result from 20 datasets revealed significant association between decreased PTEN expression and poor OS in patients with NSCLC (HR = 0.48, 95% CI: 0.43–0.54, P < 0.001) (Figure 2). The gene discussed is PTEN; the disease is non-small cell lung carcinoma.